Developmental origins of aging in brain and blood vessels: An overview

Neurobiology of Aging

Volumn 26, Issue 3, 2005, Pages 281-291

  Finch, Caleb E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Blood vessel; Brain

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; ANTITHROMBOCYTIC AGENT; APOLIPOPROTEIN E4; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL OCCLUSION; BRAIN BLOOD VESSEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL LINEAGE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DOWN SYNDROME; DRUG MECHANISM; FOAM CELL; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LOW DRUG DOSE; MACROPHAGE; MICROGLIA; MONOCYTE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RISK FACTOR; SENILE PLAQUE; STROKE;

AGING; ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOOD VESSELS; BRAIN; ENZYME INHIBITORS; HUMANS; INFLAMMATION; SENILE PLAQUES; VASCULAR DISEASES;

EID: 11444257052     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.03.015     Document Type: Conference Paper

References (160)

1. M. Akima, H. Nonaka, M. Kagesawa, and K. Tanaka A study on the microvasculature of the cerebral cortex. Fundamental architecture and its senile change in the frontal cortex Lab Invest 55 1986 482 489
2. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and G.M. Cole Inflammation and Alzheimer's disease Neurobiol Aging. 21 2000 383 421
3. M.A. Albert, E. Danielson, N. Rifai, and P.M. Ridker Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70
4. A. Alzheimer Uber eigenartige Krankheitsfalle des spateren Alters Allgem Zeits Psychiatr Psych-Gerich Med. 64 1907 146 148 [Karvik L, Greenson H, Trans.; On certain peculiar diseases of old age, Alz Dis Assoc Disord 1987;1:7-8)
5. B.H. Anderton Changes in the ageing brain in health and disease Philos Trans R Soc Lond B, Biol Sci 352 1997 1781 1792
6. Anonymous, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. Br Med J 2002;324:71-86.
7. K. Arelin, A. Kinoshita, C.M. Whelan, M.C. Irizarry, G.W. Rebeck, and D.K. Strickland LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes Brain Res Mol Brain Res 104 2002 38 46
8. B.J. Bacskai, S.T. Kajdasz, M.E. McLellan, D. Games, P. Seubert, and D. Schenk Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy J Neurosci 22 2002 7873 7878
9. M. Benagiano, A. Azzurri, A. Ciervo, A. Amedei, C. Tamburini, and M. Ferrari T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions PNAS 100 2003 6658 6663
10. Berenson GS. Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging, in press.
11. Borenstein A. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging, in press.
12. D. Bouthillier, C.F. Sing, and J. Davignon Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings J Lipid Res 24 1983 1060 1069
13. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
14. H. Braak, E. Braak, J. Bohl, and H. Bratzke Evolution of Alzheimer's disease related cortical lesions J Neural Trans Suppl 54 1998 97 106
15. J.C. Breitner NSAIDs and Alzheimer's disease: how far to generalise from trials? Lancet Neurol 2 2003 527
16. P. Bretsky, J.M. Guralnik, L. Launer, M. Albert, and T.E. Seeman The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging Neurology 60 2003 1077 1081
17. P.M. Bretsky, J.G. Buckwalter, T.E. Seeman, C.A. Miller, J. Poirier, and G.D. Schellenberg Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease Alzh Dis Assoc Disord 13 1999 216 221
18. B.G. Brown, X.Q. Zhao, D.E. Sacco, and J.J. Albers Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease Ann Rev Med 44 1993 365 376
19. M.P. Burns, W.J. Noble, V. Olm, K. Gaynor, E. Casey, and J. LaFrancois Co-localization of cholesterol, apolipoprotein E and fibrillar A[beta] in amyloid plaques Mol Brain Res 110 2003 119 125
20. G. Caligiuri, D. Stahl, S. Kaveri, T. Irinopoulous, F. Savoie, and C. Mandet Autoreactive antibody repertoire is perturbed in atherosclerotic patients Lab Invest 83 2003 939 947
21. G.N. Chaldakov, I.S. Stankulov, M. Fiore, P.I. Ghenev, and L. Aloe Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis Atherosclerosis 159 2001 57 66
22. Chan-Ling T. Microvascular and cellular changes in the CNS during physiological aging. Neurobiol Aging, in press.
23. Colton CA, Sex. ApoE and the innate immune response. Neurobiol Aging, in press.
24. F. Coria, E. Castaäno, F. Prelli, M. Larrondo-Lillo, S. van Duinen, and M.L. Shelanski Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis Lab Invest 58 1988 454 458
25. M. Crisby, L.A. Carlson, and B. Winblad Statins in the prevention and treatment of Alzheimer disease Alz Dis Assoc Disord 16 2002 131 136
26. H. Davies Atherogenesis and the coronary arteries of childhood Int J Cardiol 28 1990 283 291
27. P. Dandona, A. Aljada, and A. Bandyopadhyay Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 2004 4 7
28. O.J. de Boer, F. Hirsch, A.C. van der Wal, C.M. van der Loos, P.K. Das, and A.E. Becker Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation Atherosclerosis 133 1997 227 234
29. G.R. De Meyer, D.M. De Cleen, S. Cooper, M.W. Knaapen, D.M. Jans, and W. Martinet Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis Circ Res 90 2002 1197 1204
30. R. Del Bo, G.P. Comi, N. Bresolin, E. Castelli, E. Conti, and A. Degiuli The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects J Neurol Sci 145 1997 87 91
31. A. Delacourte General and dramatic glial reaction in Alzheimer brains Neurology 40 1990 33 37
32. P.L. DiPatre, and B.B. Gelman Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus J Neuropathol Exp Neurol 56 1997 143 149
33. P. Eikelenboom, and F.C. Stam Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study Acta Neuropathol (Berl) 57 1982 239 242
34. M. Etminan, S. Gill, and A. Samii Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies Br Med J 327 2003 128 133
35. M. Fiala, L. Zhang, X. Gan, B. Sherry, D. Taub, and M.C. Graves Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model Mol Med 4 1998 480 489
36. C.E. Finch, and V. Longo The gero-inflammatory manifold J. Rogers Neuroinflammatory mechanisms in Alzheimer's disease: basic and clinical research 2000 Birkhäuser Verlag Basel 237 256 [Chapter 1]
37. C.E. Finch, T.E. Morgan, I. Rozovsky, Z. Xie, R. Weindruch, and T. Prolla Microglia and aging in the brain W.J. Streit Microglia in the regenerating and degenerating central nervous system 2002 Springer-Verlag New York 275 305
38. G.C. Fonarow, and K.E. Watson Effective strategies for long-term statin use Am J Cardiol 92 2003 27i 34i
39. E. Ghebremedhin, C. Schultz, E. Braak, and H. Braak High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes Exp Neurol 153 1998 152 155
40. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 1984 885 890
41. Y. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, and C.E. Finch Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss PNAS 100 2003 10417 10422
42. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, and F. Checler Intraneuronal Abeta42 accumulation in human brain Am J Pathol 156 2000 15 20
43. Griffin ST. Cytokines, aging and neurodegenerative disease. Neurobiol Aging, in press.
44. W.S. Griffin, L.C. Stanley, C. Ling, L. White, V. MacLeod, and L.J. Perrot Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease PNAS 86 1989 7611 7615
45. D.E. Grobbee, and M.L. Bots Statin treatment and progression of atherosclerotic plaque burden Drugs 63 2003 893 911
46. K.A. Gyure, R. Durham, W.F. Stewart, J.E. Smialek, and J.C. Troncoso Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome Arch Pathol Lab Med 125 2001 489 492
47. T. Häkkinen, K. Karkola, and S. Ylä-Herttuala Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions Virchows Arch 437 2000 396 405
48. G.K. Hansson The B cell: a good guy in vascular disease? Arterioscl Thromb Vasc Biol 22 2002 523 524
49. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
50. E. Head, B.Y. Azizeh, I.T. Lott, A.J. Tenner, C.W. Cotman, and D.H. Cribbs Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome Neurobiol Dis 8 2001 252 265
51. E. Head, I.T. Lott, D.H. Cribbs, C.W. Cotman, and T.T. Rohn Beta-amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome Neurosci Lett 330 2002 99 103
52. R. Henriques de Gouveia, A.C. van der Wal, C.M. van der Loos, and A.E. Becker Sudden unexpected death in young adults. Discrepancies between initiation of acute plaque complications and the onset of acute coronary death Eur Heart J 23 2002 1433 1440
53. J. Hirvonen, S. Ylèa-Herttuala, H. Laaksonen, M. Mèottèonen, T. Nikkari, and E. Pesonen Coronary intimal thickenings and lipids in Finnish children who died violently Acta Paediatr Scand Suppl 1985 318
54. Y. Huo, A. Schober, S.B. Forlow, D.F. Smith, M.C. Hyman, and S. Jung Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 2003 61 67
55. O. Isacson, H. Seo, L. Lin, D. Albeck, and A.C. Granholm Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh Trends Neurosci 25 2002 79 84
56. K. Ishihara, and T. Hirano IL-6 in autoimmune disease and chronic inflammatory proliferative disease Cytokine Growth Factor Rev 13 2002 357 368
57. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
58. C.H. Kawas, and R. Katzman Epidemiology of dementia and Alzheimer disease J. Morris R. Terry R. Katzman K. Bick S. Sisodia Alzheimer disease 1999 Lippincott Williams & WiIlkins Philadelphia 95 116
59. J.L. Kelley, D.S. Chi, W. Abou-Auda, J.K. Smith, and G. Krishnaswamy The molecular role of mast cells in atherosclerotic cardiovascular disease Mol Med Today 6 2000 304 308
60. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24 2001 219 224
61. J.D. Klingensmith, P. Schoenhagen, A. Tajaddini, S.S. Halliburton, E.M. Tuzcu, and S.E. Nissen Automated three-dimensional assessment of coronary artery anatomy with intravascular ultrasound scanning Am Heart J 145 2003 795 805
62. M.A. Konstam, M.R. Weir, A. Reicin, D. Shapiro, R.S. Sperling, and E. Barr Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib Circulation 104 2001 2280 2288
63. Launer L. Mid-life risk factors for late-life dementia: lessons from epidemiologic studies. Neurobiol Aging, in press.
64. L.J. Launer, P. Scheltens, J. Lindeboom, F. Barkhof, H.C. Weinstein, and C. Jonker Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates Neurology 45 1995 747 752
65. M.R. Law, N.J. Wald, and A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis Br Med J 326 2003 1423
66. C.K. Lee, R. Weindruch, and T.A. Prolla Gene-expression profile of the ageing brain in mice Nat Genet 25 2000 294 297
67. E.A. Leistikow Is coronary artery disease initiated perinatally? Semin Thromb Hemost 24 1998 139 143
68. X.A. Li, K. Hatanaka, H. Ishibashi-Ueda, C. Yutani, and A. Yamamoto Characterization of serum amyloid P component from human aortic atherosclerotic lesions Arterioscler Thromb Vasc Biol 15 1995 252 257
69. Lott IT. Development and dementia in Down Syndrome: implications for Alzheimer's disease. Neurobiol Aging, in press.
70. C. Madsen, F. Dagnaes-Hansen, J. Miller, and E. Falk Hypercholesterolemia in pregnant mice does not affect atherosclerosis in adult offspring Atherosclerosis 168 2003 221 228
71. R.W. Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Ann Rev Genomics Human Genet 1 2000 507 537
72. M.O. McCarron, C.J. Weir, K.W. Muir, K.L. Hoffmann, C. Graffagnino, and J.A. Nicoll Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage Acta Neurol Scand 107 2003 106 109
73. M.F. McCarty Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline Med Hypotheses 52 1999 465 477
74. P.L. McGeer, A. Klegeris, D.G. Walker, O. Yasuhara, and E.G. McGeer Pathological proteins in senile plaques Tohoku J Exp Med 174 1994 269 277
75. P.L. McGeer, E.G. McGeer, and K. Yasojima Cardiovascular events and COX-2 inhibitors JAMA 286 2001 2810
76. P.L. McGeer, M. Schulzer, and E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
77. H.C. McGill Jr., E.E. Herderick, C.A. McMahan, A.W. Zieske, G.T. Malcolm, and R.E. Tracy Atherosclerosis in youth Minerva Pediatr 54 2002 437 447
78. M.E. McLellan, S.T. Kajdasz, B.T. Hyman, and B.J. Bacskai In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy J Neurosci 23 2003 2212 2217
79. J.J. McNamara, M.A. Molot, J.F. Stremple, and R.T. Cutting Coronary artery disease in combat casualties in Vietnam JAMA 216 1971 1185 1187
80. R.L. Meek, S. Urieli-Shoval, and E.P. Benditt Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function PNAS 91 1994 3186 3190
81. G. Millonig, G.T. Malcom, and G. Wick Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study Atherosclerosis 160 2002 441 448
82. M. Mishto, A. Santoro, E. Bellavista, M. Bonafe, D. Monti, and C. Franceschi Immunoproteasomes and immunosenescence Ageing Res Rev 2 2003 419 432
83. T. Miyata, R. Inagi, Y. Iida, M. Sato, N. Yamada, and O. Oda Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1 J Clin Invest 93 1994 521 528
84. T.E. Morgan, Z. Xie, S. Goldsmith, T. Yoshida, A.S. Lanzrein, and D. Stone The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction Neuroscience 89 1999 687 699
85. C. Mori, E.T. Spooner, K.E. Wisniewsk, T.M. Wisniewski, H. Yamaguch, and T.C. Saido Intraneuronal Abeta42 accumulation in Down syndrome brain Amyloid 9 2002 88 102
86. T. Mori, D. Paris, T. Town, A.M. Rojiani, D.L. Sparks, and A. Delledonne Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice J Neuropathol Exp Neurol 60 2001 778 785
87. J.C. Morris Clinical presentation and course of Alzheimer disease R.D. Terry R. Katzman K.L. Bick S.S. Soisodia Alzheimer disease 1999 Lippincott Williams & WiIlkins Philadelphia 11 24
88. J.C. Morris, and A.L. Price Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease J Mol Neurosci 17 2001 101 118
89. Morrison JH. Personal communication.
90. C. Napoli, F.P. D'Armiento, F.P. Mancini, A. Postiglione, J.L. Witztum, and G. Palumbo Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions J Clin Invest 100 1997 2680 2690
91. C. Napoli, F. de Nigris, J.S. Welch, F.B. Calara, R.O. Stuart, and C.K. Glass Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray Circulation 105 2002 1360 1367
92. C. Napoli, C.K. Glass, J.L. Witztum, R. Deutsch, F.P. D'Armiento, and W. Palinski Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study Lancet 354 1999 1234 1241
93. Napoli C, Palinski W. Pathogenic mechanism and effects. Neurobiol Aging, in press.
94. T. Nassar, B.S. Sachais, S. Akkawi, M.A. Kowalska, K. Bdeir, and E. Leitersdorf Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells J Biol Chem 278 2003 6187 6193
95. Nixon R. Genetic influences on proteolysis in aging and aging-related neurodegenerative disease. Neurobiol Aging, in press.
96. A. Nunomura, G. Perry, M.A. Pappolla, R.P. Friedland, K. Hirai, and S. Chiba Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome J Neuropathol Exp Neurol 59 2000 1011 1017
97. T. Oda, P. Wals, H.H. Osterburg, S.A. Johnson, G.M. Pasinetti, and T.E. Morgan Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress Exp Neurol 136 1995 22 31
98. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, and R. Kayed Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
99. T.G. Ohm, H. Mèuller, H. Braak, and J. Bohl Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes Neuroscience 64 1995 209 217
100. W. Palinski, and C. Napoli The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis FASEB J 16 2002 1348 1360
101. W. Palinski, and S. Tsimikas Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis J Am Soc Nephrol 13 2002 1673 1681
102. G.M. Pasinetti, M. Hassler, D. Stone, and C.E. Finch Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions Synapse 31 1999 278 284
103. R. Peila, L.R. White, H. Petrovich, K. Masaki, G.W. Ross, and R.J. Havlik Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia Aging Study Stroke 32 2001 2882 2889
104. L.S. Perlmutter, H.C. Chui, D. Saperia, and J. Athanikar Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease Brain Res 508 1990 13 19
105. J. Poirier Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism Ann N Y Acad Sci 924 2000 81 90
106. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Neurobiol Aging, in press.
107. J.L. Price, A.I. Ko, M.J. Wade, S.K. Tsou, D.W. McKeel, and J.C. Morris Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease Arch Neurol 58 2001 1395 1402
108. J.L. Price, and J.C. Morris Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 45 1999 358 368
109. Reiman EM. PET in the study of aging and the genetic predisposition to Alzheimer's disease. Neurobiol Aging, in press.
110. E.M. Reiman, R.J. Caselli, K. Chen, G.E. Alexander, D. Bandy, and J. Frost Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease PNAS 98 2001 3334 3339
111. P.M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813 1818
112. P.M. Ridker Role of inflammatory biomarkers in prediction of coronary heart disease Lancet 358 2001 946 948
113. Riley K. Early life factors, mild cognitive impairment, and the neuropathology of Alzheimer's disease: findings from the Nun study. Neurobiol Aging, in press.
114. M.S. Rolph, S. Zimmer, B. Bottazzi, C. Garlanda, A. Mantovani, and G.K. Hansson Production of the long pentraxin PTX3 in advanced atherosclerotic plaques Arterioscl Thromb Vasc Biol 22 2002 e10 e14
115. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
116. R. Ross Cell biology of atherosclerosis Annu Rev Physiol 57 1995 791 804
117. B. Rumble, R. Retallack, C. Hilbich, G. Simms, G. Multhaup, and R. Martins Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease N Engl J Med 320 1989 1446 1452
118. H.G. Rus, R. Vlaicu, and F. Niculescu Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 127 1996 263 271
119. M. Sastre, I. Dewachter, G.E. Landreth, T.M. Willson, T. Klockgether, and F. van Leuven Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J Neurosci 23 2003 9796 9804
120. Y. Sato, F. Inoue, A. Yoshimura, T. Fukui, T. Imazeki, and M. Kato Regression of an atherosclerotic coronary artery plaque demonstrated by multislice spiral computed tomography in a patient with stable angina pectoris Heart Vessels 18 2003 224 226
121. A.M. Saunders, M.K. Trowers, R.A. Shimkets, S. Blakemore, D.J. Crowther, and T.A. Mansfield The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection Biochim Biophys Acta 1502 2000 85 94
122. A. Scuteri, A.J. Bos, A.B. Zonderman, L.J. Brant, E.G. Lakatta, and J.L. Fleg Is the apoE4 allele an independent predictor of coronary events? Am J Med 110 2001 28 32
123. R. Schmidt, H. Schmidt, J.D. Curb, K. Masaki, L.R. White, and L.J. Launer Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study Ann Neurol 52 2002 168 174
124. D. Senitz, A. Reichenbach, and T.G. Smith Jr. Surface complexity of human neocortical astrocytic cells: changes with development, aging, and dementia J Hirnforsch 36 1995 531 537
125. J.G. Sheng, R.E. Mrak, K.R. Bales, B. Cordell, S.M. Paul, and R.A. Jones Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice J Neurochem 74 2000 295 301
126. K. Shoghi-Jadid, G.W. Small, E.D. Agdeppa, V. Kepe, L.M. Ercoli, and P. Siddarth Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am J Geriatr Psychiatry 10 2002 24 35
127. S.K. Singhrao, B.P. Morgan, J.W. Neal, and G.R. Newman A functional role for corpora amylacea based on evidence from complement studies Neurodegeneration 4 1995 335 345
128. G.W. Small, L.M. Ercoli, D.H. Silverman, S.C. Huang, S. Komo, and S.Y. Bookheimer Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease PNAS 97 2000 6037 6042
129. K.M. Spangler, V.R. Challa, D.M. Moody, and M.A. Bell Arteriolar tortuosity of the white matter in aging and hypertension. A microradiographic study J Neuropathol Exp Neurol 53 1994 22 26
130. D.L. Sparks Intraneuronal beta-amyloid immunoreactivity in the CNS Neurobiol Aging 17 1996 291 299
131. D.L. Sparks, T.A. Martin, D.R. Gross, and J.C. Hunsaker 3rd Link between heart disease, cholesterol, and Alzheimer's disease: a review Microsc Res Tech 50 2000 287 290
132. H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull Jr., and M.E. Rosenfeld A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 89 1994 2462 2478
133. O. Stèuve, S. Youssef, L. Steinman, and S.S. Zamvil Statins as potential therapeutic agents in neuroinflammatory disorders Curr Opin Neurol 16 2003 393 401
134. S.E. Stoltzner, T.J. Grenfell, C. Mori, K.E. Wisniewski, T.M. Wisniewski, and D.J. Selkoe Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease Am J Pathol 156 2000 489 499
135. W.J. Streit Microglia as neuroprotective, immunocompetent cells of the CNS Glia 40 2002 133 139
136. S.L. Stuesse, W.L. Cruce, J.A. Lovell, D.L. McBurney, and T. Crisp Microglial proliferation in the spinal cord of aged rats with a sciatic nerve injury Neurosci Lett 287 2000 121 124
137. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, and R. Hill Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
138. D.R. Thal, C. Schultz, F. Dehghani, H. Yamaguchi, H. Braak, and E. Braak Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex Acta Neuropathol 100 2000 608 617
139. J. Torzewski, M. Torzewski, D.E. Bowyer, M. Frohlich, W. Koenig, and J. Waltenberger C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol. 18 1998 1386 1392
140. E.M. Tuzcu, and P. Schoenhagen Acute coronary syndromes, plaque vulnerability, and carotid artery disease: the changing role of atherosclerosis imaging J Am Coll Cardiol 42 2003 1033 1036
141. E.M. Tuzcu, S.R. Kapadia, E. Tutar, K.M. Ziada, R.E. Hobbs, and P.M. McCarthy High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound Circulation 103 2001 2705 2710
142. A.H. Vagnucci Jr., and W.W. Li Alzheimer's disease and angiogenesis Lancet 361 2003 605 608
143. W.E. Van Nostrand, A.H. Schmaier, and S.L. Wagner Potential role of protease nexin-2/amyloid beta-protein precursor as a cerebral anticoagulant Ann N Y Acad Sci 674 1992 243 252
144. D.W. Vaughan, and A. Peters Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study J Neurocytol 3 1974 405 429
145. R. Veerhuis, M.J. Van Breemen, J.M. Hoozemans, M. Morbin, J. Ouladhadj, and F. Tagliavini Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro Acta Neuropathol 105 2003 135 144
146. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque J Intervent Cardiol 16 2003 267 272
147. P. von Hundelshausen, K.S. Weber, Y. Huo, A.E. Proudfoot, P.J. Nelson, and K. Ley RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium Circulation 103 2001 1772 1777
148. N.J. Wald, and M.R. Law A strategy to reduce cardiovascular disease by more than 80% Br Med J 326 2003 1419
149. Wang Y. Cardiovascular functional phenotypes and pathological changes in response to pharmacological stimulation of Apolipoprotein E deficient mice. Neurobiol Aging, in press.
150. Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, et al. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem 278:31831-7.
151. J. Wegiel, H. Imaki, K.C. Wang, A. Wronska, M. Osuchowski, and R. Rubenstein Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice Acta Neuropathol 105 2003 393 402
152. W.B. White, G. Faich, J.S. Borer, and R.W. Makuch Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib American J Cardiol 92 2003 411 418
153. A.S. Wierzbicki, R. Poston, and A. Ferro The lipid and non-lipid effects of statins Pharmacol Ther 99 2003 95 112
154. C.J. Wilson, C.E. Finch, and H.J. Cohen Mechanisms of cognitive impairment. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm J Am Geriartr Soc 50 2002 2041 2056
155. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch Neurol 57 2000 1439 1443
156. D. Woo, L.R. Sauerbeck, B.M. Kissela, J.C. Khoury, J.P. Szaflarski, and J. Gebel Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study Stroke 33 2002 1190 1195
157. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, and F. Yan Adult mouse astrocytes degrade amyloid-beta in vitro and in situ Nat Med 9 2003 453 457
158. Z. Xie, T.E. Morgan, I. Rozovsky, and C.E. Finch Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity Exp Neurol 182 2003 135 141
159. Zanjani H, Finch CE, Kemper C, Atkinson JP, McKeel Jr DW, Morris JC, et al. Complement activation in very early Alzheimer's disease, in preparation.
160. Y. Zhou, Y. Su, B. Li, F. Liu, J.W. Ryder, and X. Wu Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho Science 302 2003 1215 1217